Driehaus Capital Management LLC Exelixis, Inc. Transaction History
Driehaus Capital Management LLC
- $9.17 Billion
- Q1 2025
A detailed history of Driehaus Capital Management LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Driehaus Capital Management LLC holds 463,949 shares of EXEL stock, worth $20.5 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
463,949
Previous 346,943
33.72%
Holding current value
$20.5 Million
Previous $11.6 Million
48.26%
% of portfolio
0.19%
Previous 0.11%
Shares
2 transactions
Others Institutions Holding EXEL
# of Institutions
617Shares Held
257MCall Options Held
1.57MPut Options Held
730K-
Black Rock Inc. New York, NY33.5MShares$1.48 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA28.7MShares$1.27 Billion0.02% of portfolio
-
Farallon Capital Management LLC San Francisco, CA22.5MShares$995 Million4.78% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny14.8MShares$655 Million0.88% of portfolio
-
State Street Corp Boston, MA11.8MShares$521 Million0.02% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $14.2B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...